Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC) Meeting Abstract
| Authors: | Sinicrope, F. A.; Ou, F. S.; Arnold, D.; Peters, W.; Behrens, R. J.; Lieu, C. H.; Matin, K.; Cohen, D. J.; Potter, S. L.; Frankel, W. L.; Shergill, A.; Hsu, D.; Reinacher-Schick, A. C.; Zemla, T.; Gatten, C. A.; O'Reilly, E. M.; Meyerhardt, J. A. |
| Abstract Title: | Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC) |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 17 Suppl. |
| Meeting Dates: | 2025 ASCO Annual Meeting |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-10 |
| Start Page: | LBA1 |
| Language: | English |
| ACCESSION: | WOS:001511774100001 |
| DOI: | 10.1200/JCO.2025.43.17_suppl.LBA1 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
